Compare stocks

Medartis Holding AG is a Swiss company operating in the medical technology industry, primarily focused on the development, manufacturing, and distribution of orthopedic surgical implants. The company's core products include precision implant systems for surgical fixation of bone fractures and osteotomies, particularly in the areas of the head, hand, wrist, foot, and ankle. Founded in 1997 and headquartered in Basel, Switzerland, Medartis has established a presence in key international markets across Europe, the Americas, and Asia-Pacific. The company's strategic positioning emphasizes innovation in implant technology, aiming for high standards of surgical precision and patient recovery outcomes.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.